Cardiovascular Business March 23, 2023
Dave Fornell

In her research at Mayo, Pellikka has been involved with the development of AI that looks at the ultrasound images to directly detect disease. The algorithms can pick out radiomic signatures of disease in the image that may not be evident to the human eye. “I think the potential there is enormous,” Pellikka said.

She collaborated with the AI vendor Ultromics on its EchoGo algorithms to detect heart failure patients with preserved ejection fraction (HFpEF) by looking at a single apical four-chamber view. HFpEF can be difficult to detect, and this is the first AI cleared to detect it, filling an unmet need. The technology received the FDA’s breakthrough device designation and was then cleared by the FDA at the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Provider, Technology
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Google DeepMind unveils ‘superhuman’ AI system that excels in fact-checking, saving costs and improving accuracy
Katie Couric Talks Colon Cancer, Health Equity And AI
5 tips on AI adoption from a frontline physician champion
Survey of Oncologists Finds Agreement, Concerns Over AI Use

Share This Article